AT322097B - Verfahren zur isolierung eines neuen schwangerschaftsspezifischen beta 1-glykoproteins - Google Patents

Verfahren zur isolierung eines neuen schwangerschaftsspezifischen beta 1-glykoproteins

Info

Publication number
AT322097B
AT322097B AT834772A AT834772A AT322097B AT 322097 B AT322097 B AT 322097B AT 834772 A AT834772 A AT 834772A AT 834772 A AT834772 A AT 834772A AT 322097 B AT322097 B AT 322097B
Authority
AT
Austria
Prior art keywords
glycoprotein
isolating
specific beta
pregnancy specific
new pregnancy
Prior art date
Application number
AT834772A
Other languages
English (en)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712148587 external-priority patent/DE2148587A1/de
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Priority to AT239674A priority Critical patent/AT330351B/de
Application granted granted Critical
Publication of AT322097B publication Critical patent/AT322097B/de
Priority to AT491875A priority patent/AT330357B/de
Priority to AT491975A priority patent/AT330358B/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT834772A 1971-09-29 1972-09-28 Verfahren zur isolierung eines neuen schwangerschaftsspezifischen beta 1-glykoproteins AT322097B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT239674A AT330351B (de) 1971-09-29 1974-03-22 Verfahren zum nachweis und/oder zur uberwachung einer schwangerschaft
AT491875A AT330357B (de) 1971-09-29 1975-06-26 Verfahren zur herstellung eines anti-schwangerschaftsspezifischen -beta 1- glykoprotein-serums
AT491975A AT330358B (de) 1971-09-29 1975-06-26 Diagnostisches mittel zum nachweis und zur uberwachung einer schwangerschaft

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19712148587 DE2148587A1 (de) 1971-09-29 1971-09-29 Schwangerschaftsspezifisches beta tief 1-glykoprotein und verfahren zu seiner isolierung
DE2157610A DE2157610C3 (de) 1971-09-29 1971-11-20 Schwangerschaftsspezifisches ß , -Glykoprotein, Verfahren zu seiner Isolierung und seine Verwendung für die Herstellung von Antiseren

Publications (1)

Publication Number Publication Date
AT322097B true AT322097B (de) 1975-05-12

Family

ID=25761802

Family Applications (1)

Application Number Title Priority Date Filing Date
AT834772A AT322097B (de) 1971-09-29 1972-09-28 Verfahren zur isolierung eines neuen schwangerschaftsspezifischen beta 1-glykoproteins

Country Status (15)

Country Link
JP (1) JPS522970B2 (de)
AT (1) AT322097B (de)
AU (1) AU448871B2 (de)
BE (1) BE789523A (de)
CA (1) CA986014A (de)
DE (1) DE2157610C3 (de)
DK (1) DK135269C (de)
ES (1) ES406976A1 (de)
FI (1) FI53317C (de)
FR (1) FR2157816B1 (de)
GB (1) GB1410338A (de)
IT (1) IT967943B (de)
NL (1) NL155654B (de)
NO (1) NO141051C (de)
SE (2) SE7508321L (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2267115B1 (de) * 1974-04-12 1977-11-10 Merieux Inst
JPS541641U (de) * 1977-06-03 1979-01-08
JPS5654317Y2 (de) * 1977-09-30 1981-12-17
JPS5458931U (de) * 1977-09-30 1979-04-24

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB466749A (en) * 1935-11-11 1937-06-04 Frank B Hubachek Antigen for the determination of pregnancy
GB520077A (en) * 1938-08-12 1940-04-15 Henri Georges Bouly Improvements in and relating to the production of sensitising agents for use in the determination of pregnancy

Also Published As

Publication number Publication date
IT967943B (it) 1974-03-11
AU4716072A (en) 1974-04-04
BE789523A (fr) 1973-03-29
DE2157610A1 (de) 1973-05-24
DK135269C (da) 1977-10-03
DE2157610C3 (de) 1979-08-30
FI53317B (de) 1977-12-30
NL155654B (nl) 1978-01-16
NO141051B (no) 1979-09-24
DE2157610B2 (de) 1978-11-30
CA986014A (en) 1976-03-23
FI53317C (fi) 1978-04-10
AU448871B2 (en) 1974-05-30
NL7212857A (de) 1973-04-02
NO141051C (no) 1980-01-09
FR2157816B1 (de) 1976-03-12
FR2157816A1 (de) 1973-06-08
JPS522970B2 (de) 1977-01-25
SE7508322L (sv) 1975-07-22
ES406976A1 (es) 1976-02-01
DK135269B (da) 1977-03-28
JPS4840911A (de) 1973-06-15
GB1410338A (en) 1975-10-15
SE7508321L (sv) 1975-07-22

Similar Documents

Publication Publication Date Title
AT321923B (de) Verfahren zur herstellung von neuen imidazotriazinonen
AT348138B (de) Verfahren zur herstellung eines neuen komplexes
AT309398B (de) Verfahren zur Herstellung von neuen 1-Crotonylcyclohex-2-enen
AT333986B (de) Verfahren zur herstellung von neuen polypeptiden
AT322097B (de) Verfahren zur isolierung eines neuen schwangerschaftsspezifischen beta 1-glykoproteins
AT318802B (de) Verfahren zur Gewinnung eines neuen Hormons
AT308964B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT325043B (de) Verfahren zur herstellung der neuen 5- oder 7-chlorsulfonylxanthon-2-carbonsäuren
AT323162B (de) Verfahren zur herstellung von neuen 3-sulfoalkyl-6-hydroxy-pyridonen-(2)
AT303253B (de) Verfahren zur Herstellung eines neuen Amylase-Inhibitors
AT306716B (de) Verfahren zur Herstellung eines neuen Benzopyron-Derivates
AT315196B (de) Verfahren zur Herstellung von neuen 6-Hydroxy-dihydro-uracilen
AT315368B (de) Verfahren zur Herstellung eines neuen Antibioticums
CH537915A (de) Verfahren zur Herstellung eines neuen Östratriols
AT305992B (de) Verfahren zur Herstellung von neuen Decahydro-3-H-benz[e]indenen
AT310771B (de) Verfahren zur Herstellung von neuen Phosphinyl-alkylaminobenzophenonen
AT306925B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT329193B (de) Verfahren zur herstellung von neuen cardenolidglykosiden
AT310944B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT311554B (de) Verfahren zur Herstellung eines neuen Antibiotikums
AT307415B (de) Verfahren zur Herstellung von neuen Thiazolon-(2)-derivaten
AT335424B (de) Verfahren zur herstellung von neuen phenyl-benzyl-ketonen
AT329176B (de) Verfahren zur herstellung von neuen penicillinen
AT328074B (de) Verfahren zur herstellung eines neuen antibiotikums
AT302547B (de) Verfahren zur Herstellung von neuen 3β-Alkoxymethoxy-14-hydroxy-5β-card-20(22)-enoliden

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee